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abstract
 
The effects of the muscle relaxant dantrolene on steps of excitation-contraction coupling were stud-
ied on fast twitch muscles of rodents. To identify the site of action of the drug, single fibers for voltage-clamp mea-
surements, heavy SR vesicles for calcium efflux studies and solubilized SR calcium release channels/RYRs for lipid
bilayer studies were isolated. Using the double Vaseline-gap or the silicone-clamp technique, dantrolene was
found to suppress the depolarization-induced elevation in intracellular calcium concentration ([Ca
 
2
 

 
]
 
i
 
) by inhib-
iting the release of calcium from the SR. The suppression of [Ca
 
2
 

 
]
 
i
 
 was dose-dependent, with no effect at or be-
low 1 
 

 
M and a 53 
 

 
 8% (mean 
 

 
 SEM, 
 
n
 
 
 

 
 9, cut fibers) attenuation at 0 mV with 25 
 

 
M of extracellularly ap-
plied dantrolene. The drug was not found to be more effective if injected than if applied extracellularly. Calculat-
ing the SR calcium release revealed an equal suppression of the steady (53 
 

 
 8%) and of the early peak
component (46 
 

 
 6%). The drug did not interfere with the activation of the voltage sensor in as much as the volt-
age dependence of both intramembrane charge movements and the L-type calcium currents (I
 
Ca
 
) were left, essen-
tially, unaltered. However, the inactivation of I
 
Ca
 
 was slowed fourfold, and the conductance was reduced from
200 
 

 
 16 to 143 
 

 
 8 SF
 

 
1
 
 (
 
n
 
 
 

 
 10). Dantrolene was found to inhibit thymol-stimulated calcium efflux from heavy
SR vesicles by 44 
 

 
 10% (
 
n
 
 
 

 
 3) at 12 
 

 
M. On the other hand, dantrolene failed to affect the isolated RYR incor-
porated into lipid bilayers. The channel displayed a constant open probability for as long as 30–50 min after the
application of the drug. These data locate the binding site for dantrolene to be on the SR membrane, but be dis-
tinct from the purified RYR itself.
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I N T R O D U C T I O N
 
In susceptible individuals, the inhalation of certain vol-
atile anesthetics triggers a sudden increase in body tem-
perature, which, if left untreated, is usually lethal. The
underlying reason for this increase in body tempera-
ture (malignant hyperthermia [MH]*) is the abnormal
activation of skeletal muscle fibers and the consequent
increase in metabolic rate throughout the body. In
MH, apparently, the presence of the anesthetic is suffi-
cient to trigger the release of calcium from its internal
store, the SR in resting, unstimulated skeletal muscle fi-
bers. To prevent this increase in muscle activity, dan-
trolene is administered. Dantrolene itself is a hydan-
toid derivative muscle relaxant that has been shown to
decrease contractile force (Flewellen et al., 1983) and
shift the excitation threshold to more positive voltages
(Hainaut and Desmedt, 1974). In spite of the fact that
dantrolene plays a pivotal role in MH treatment and its
effects on most major steps of excitation-contraction
coupling have been investigated, the actual site of dan-
trolene action is still controversial.
During normal excitation of a skeletal muscle fiber
the change in transverse (t)-tubular voltage governs the
conformational changes of the t-tubular dihydropyri-
dine receptors (DHPRs) acting as voltage sensors. The
interaction of the DHPRs with the calcium release
channel of the SR, the RYRs, leads to the release of cal-
cium from the SR into the myoplasmic space. In MH,
this chain of events is disrupted, and calcium release
can occur even in the absence of voltage sensor activa-
tion. The effect of dantrolene is, by a yet unknown
mechanism, to suppress SR calcium release.
It is currently accepted that dantrolene must, either
directly or indirectly, affect the RYR itself (Parness and
Palnitkar, 1995; Nelson et al., 1996; Pessah et al., 1996;
Palnitkar et al., 1997). Several lines of evidence favor
this interpretation. Measurements have shown that in-
tramembrane charge movement is slightly reduced,
and its voltage dependence is shifted to more positive
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P
 
o
 
,
open probability; R
 
rel
 
, rate of calcium release from the SR; t-tubu-
lar, transverse tubular.
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voltages (Hui, 1983; Jong et al., 1997). The effect of the
drug was preferentially on the Q
 

 
 component (Hui,
1983). Considering the proposed connection between
Q
 

 
 and calcium release (Pizarro et al., 1991; Jong et al.,
1995), these observations link the effects of dantrolene
to SR calcium release.
Dantrolene or its water-soluble analogue azumolene
has been reported to inhibit calcium efflux from heavy
SR vesicles (Francis, 1978; Fruen et al., 1997). Not only
were these drugs shown to reduce doxorubicin (Tian et
al., 1991) or calcium- and calmodulin-induced (Fruen
et al., 1997) calcium release, but dantrolene was also
shown to inhibit [
 
3
 
H]ryanodine binding to SR mem-
brane fractions. Furthermore, [
 
3
 
H]dantrolene and
[
 
3
 
H]ryanodine binding sites were localized to closely
associated SR membrane fractions from skeletal muscle
(Parness and Palnitkar, 1995; Palnitkar et al., 1997).
Single-channel measurements have revealed a high af-
finity activatory and a lower affinity inhibitory binding
site on the SR membrane (Nelson et al., 1996).
Despite this close association, the calcium release
channel and the dantrolene-binding site in skeletal mus-
cle have not been equated. On the one hand, Fruen and
co-workers (Fruen et al., 1997) have shown that isolated
RYR reconstituted into liposomes display a reduced
[
 
3
 
H]ryanodine binding in the presence of dantrolene,
which is indicative of a dantrolene-binding site on the
channel molecule itself. On the other hand, Palnitkar
and co-workers (Palnitkar et al., 1999) identified a 160-
kD protein in the SR membrane with a high affinity
against [
 
3
 
H]azidodantrolene as the putative binding
site. However, recently, the same authors (Paul-Pletzer et
al., 2001) have provided evidence for the 160-kD protein
to be identical with the NH
 
2
 
 terminus of the RYR. Sin-
gle-channel data that could resolve the controversy were
obtained from vesicles incorporated into planar lipid bi-
layers (Suarez-Isla et al., 1986; Nelson et al., 1996), leav-
ing the possibility of an SR membrane–bound molecule
to be the dantrolene-binding site open.
To date, three isoforms of the calcium release chan-
nel have been identified in mammals. In spite of the
homology between isoforms found, predominantly, in
skeletal (RYR1) and cardiac (RYR2) muscles, dan-
trolene is known to preferentially inhibit calcium re-
lease in skeletal, but not in cardiac muscle (Chamber-
lain et al., 1984). Although the inhibitory effect of dan-
trolene on calcium release from internal stores in
neurons has been demonstrated (Nelson et al., 1999),
the involvement of RYR3 in this effect remains to be
elucidated, since neurons are known to express all
three RYR isoforms. A possible action of the drug on
RYR3 would be interesting from the therapeutic point
of view, since the expression of RYR3, although to a
limited extent, has been demonstrated in skeletal mus-
cle as well (Flucher et al., 1999).
Although dantrolene was shown to suppress the cal-
cium transients in frog skeletal muscle (Desmedt and
Hainaut, 1977; Kovács et al., 1983), similar effects in
mammalian skeletal muscle haven’t been documented
so far. Furthermore, a detailed description of the alter-
ation of SR calcium release as well as a functional com-
parison of the purified channel with the channel in na-
tive interaction with other proteins is also missing.
Here we show, for the first time, that dantrolene inhib-
its calcium release in mammalian skeletal muscle by
suppressing both steady and peak components of SR
calcium release flux. This suppression was achieved
without major alterations in the voltage dependence of
intramembrane charge movement and calcium cur-
rent. We also demonstrate that the isolation and recon-
stitution of RYR into planar lipid bilayers results in the
loss of dantrolene sensitivity, which was clearly present
when the release channel was in the SR membrane.
These data argue against a direct effect of dantrolene
on the purified RYR, but place the dantrolene-binding
site on an SR membrane–bound molecule.
 
M A T E R I A L S  A N D  M E T H O D S
 
Enzymatic Isolation of Single Fibers
 
Single skeletal muscle fibers were isolated enzymatically from the
extensor digitorum communis or flexor digitorum brevis muscles
of rats or mice and mounted into a double Vaseline gap chamber
or silicone clamp as described earlier (Szentesi et al., 1997; Jac-
quemond, 1997, respectively). In brief, rats or mice of either sex
were anesthetized and killed by cervical dislocation in accordance
with the guidelines of the European Community (86/609/EEC).
The muscles were removed and were treated with collagenase
(Type I; Sigma-Aldrich) for 1–1.5 h at 37
 

 
C. After the dissociation,
fibers were allowed to rest for at least 20 min, and only those that
showed no signs of membrane damage were used.
For the Vaseline-gap experiments, the selected fiber was trans-
ferred into a recording chamber (Kovács, et al., 1983) filled with
relaxing solution ([in mM] 150 potassium glutamate, 2 MgCl
 
2
 
, 10
HEPES, and 1 EGTA). The fiber segments in the open-end pools
were permeabilized using 0.01% saponin. After completing the
permeabilization, the solutions were exchanged to internal solu-
tion in the open-end pools ([in mM] 120 cesium glutamate, 5.5
MgCl
 
2
 
, 5 Na
 
2
 
-ATP, 10 sodium phosphocreatine, 10 glucose, 10
HEPES, and 5 EGTA) and to external solution in the middle pool
([in mM] 140 TEA-CH
 
3
 
SO
 
3
 
, 2 CaCl
 
2
 
, 2 MgCl
 
2
 
, 10 HEPES, 0.0003
tetrodotoxin, and 1 3,4-diamino-pyridine). All solutions were ad-
justed to pH 7.2 and 300 mosmol/liter. The internal solution also
contained 1 mM antipyrylazo III (APIII) and 100 
 

 
M Fura-2 for
the detection of intracellular calcium concentration. For calcium
current measurements, the external solution was modified to
have 5 mM CaCl
 
2
 
 and appropriately reduced TEA-CH
 
3
 
SO
 
3
 
,
whereas the EGTA concentration in the internal solution was in-
creased to 20 mM with reducing cesium glutamate. The length of
the fiber segment in the middle pool was set to 500 
 

 
m.
For silicone-clamp experiments, the major part of an isolated
mouse skeletal muscle fiber was electrically insulated with sili-
cone grease so as to achieve whole-cell voltage clamp on a short
portion (50–100 
 

 
m long) of the fiber extremity (Jacquemond,
1997). Intracellular indo-1 loading was then performed through
local pressure microinjection, using a micropipette containing
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0.5 mM indo-1 (pentapotassium salt) dissolved in an “intracellu-
lar-like” solution containing (in mM): 120 potassium glutamate,
5 Na
 
2
 
-ATP, 5 Na
 
2
 
-phosphocreatine, 5.5 MgCl
 
2
 
, and 10 HEPES, ad-
justed to pH 7.2 with KOH. The microinjection was performed
with the micropipette tip inserted through the silicone within the
insulated part of the fiber. Fibers were then left for a 30–45-min
period of time before voltage clamping to allow for dye equilibra-
tion throughout the entire fiber volume. In some experiments,
dantrolene was present within the injected solution at a concen-
tration of 25 
 

 
M (see 
 
Chemicals
 
). The composition of the exter-
nal solution was identical to that used for the Vaseline-gap exper-
iments, except that it contained 2.5 mM CaCl
 
2
 
, 2 
 

 
M tetrodo-
toxin, and no 3,4 diamino-pyridine. For testing the effect of
extracellularly applied dantrolene, a thin polyethylene capillary
perfusion system operating by gravity was used.
 
Optical Set-up and Voltage Clamp
 
The experimental set-up and the data acquisition have been de-
scribed in detail in our earlier reports (Jacquemond, 1997; Cser-
noch et al., 1999b). In the Vaseline gap, the fiber was trans-illu-
minated using a tungsten halogen light source (
 
	 
 
 
600 nm) and
was also epi-illuminated at 380 nm or at the isosbestic wavelength
of Fura-2 using a 75 W Xenon arc lamp (model 60000; Oriel). Us-
ing appropriate interference filters and dichroic mirrors, light
intensities were simultaneous recorded at 510, 720, and 850 nm
for the detection of APIII absorbance and Fura-2 fluorescence.
Fibers were voltage-clamped and the holding potential was set to
 

 
100 mV. In silicone-clamp experiments, the light from a high
pressure mercury bulb (model USH102DH;, USHIO INC.) was
used for fiber illumination. Excitation was set at 335 nm and fluo-
rescence was detected simultaneously at 405 and 470 nm by two
photo multipliers, using an appropriate set of filters and dichroic
mirror. Fibers were voltage-clamped at a holding potential of
 

 
80 mV using a patch-clamp amplifier (model RK-400; Bio-
Logic) in whole-cell configuration, connected to a microelec-
trode filled with the “intracellular-like” solution (see above). All
experiments were performed at room temperature (20–22
 

 
C).
 
Preparation of SR Vesicles and RYR
 
Heavy and light SR (HSR and LSR, respectively) vesicles and the
RYR calcium release channel were isolated from rat skeletal mus-
cle as described earlier (Csernoch et al., 1999b). In brief, skeletal
muscles were removed from the front and hind legs of those rats
that were used in the Vaseline-gap experiments. The muscles
were cut into small pieces, quickly frozen using liquid nitrogen,
and stored at 
 

 
70
 

 
C until further use. Vesicles were obtained by
first homogenizing the tissue, and then removing the unsolubi-
lized particles in a clinical centrifuge. Crude membrane fraction
was collected from the supernatant by centrifugation at 40,000 
 
g
 
(30 min). The actomyosin content of the pellet was then dis-
solved in 600 mM KCl, and the crude microsome fraction was
collected by centrifugation at 109,000 
 
g
 
 (30 min). The mi-
crosome was loaded onto a 20–45% linear sucrose gradient and
spun for 16 h at 90,000 
 
g
 
 (4
 

 
C) in a swing-out (SW-27) Beckman
rotor. The protein ring corresponding to the HSR fraction was
extracted from the 36–38%, whereas that for LSR was extracted
from the 32–34% region. Vesicles were collected at 124,000 
 
g
 
 for
60 min, and then resuspended in 92.5 mM KCl 
 

 
 18.5 mM
K-MOPS, pH
 
 
 
7.0, for vesicular measurements or in 0.4 M su-
crose 
 

 
 10 mM K-PIPES, pH
 
 
 
7.2, for RYR preparation. Samples
were stored at 
 

 
70
 

 
C until further use.
For preparation of RYR, the HSR vesicles (3 mg/ml) were sol-
ubilized for 2 h at 4
 

 
C with 1% CHAPS (3[(3-chloramidopro-
pyl)dimethyl-amino]-1-propanesulfonate) in a solution contain-
ing 1 M NaCl, 100 
 

 
M EGTA, 150 
 

 
M CaCl
 
2
 
, 5 mM AMP, 0.45%
phosphatidylcholine, 20 mM Na-PIPES, pH 7.2, and protease in-
hibitors (Csernoch et al., 1999b). Unsolubilized proteins were re-
moved by centrifugation at 59,000 
 
g
 
, and subsequently the super-
natant was layered on top of a 10–28% sucrose gradient also
containing 1% CHAPS, 0.7 M NaCl, 10 mM AMP, 0.5% phos-
phatidylcholine, 70 
 

 
M EGTA, 100 
 

 
M CaCl
 
2
 
, 1 mM DTT, 13
mM Na-PIPES, pH 7.2. Solubilized SR membranes were centri-
fuged through the sucrose gradient for 16 h at 90,000 
 
g
 
 (4
 

 
C) in
swing-out Beckman rotor. Fractions containing RYR were col-
lected in small aliquots. They were rapidly frozen in liquid nitro-
gen and stored at 
 

 
70
 

 
C.
 
Calculation of [Ca
 
2
 

 
]
 
i
 
 and R
 
rel
 
In Vaseline-gap experiments, the changes in myoplasmic free cal-
cium concentration ([Ca
 
2
 

 
]
 
i
 
) were calculated from APIII absor-
bance as described by Kovács et al. (1983) with the correction for
intrinsic fiber absorbance at 850 nm (Melzer et al., 1986) and from
Fura-2 fluorescence using the kinetic correction (Klein et al.,
1988). Under silicone-clamp conditions, [Ca
 
2
 

 
]
 
i
 
 was calculated
from the ratio of indo-1 fluorescence measured at 405 and 470 nm,
as described previously (Jacquemond, 1997; Collet et al., 1999).
The rate of calcium release from the SR (R
 
rel
 
) was calculated
from the calcium transients measured in Vaseline-gap experi-
ments using the procedure described in Szentesi et al. (1997).
Four parameters of the removal model were fitted simulta-
neously, k
 
off,M–P
 
 (Mg
 
2
 

 
 off rate from parvalbumin), PV
 
max
 
 (maxi-
mal transport rate of SR calcium pump), and k
 
off,Ca-E
 
 and k
 
on,Ca-E
 
(the rate constants of calcium binding to EGTA). The calculated
R
 
rel
 
 records were corrected for the depletion of calcium in the SR
and expressed as a percentage of SR content (Csernoch et al.,
1993). The voltage (V
 
m
 
) dependence of either component of cal-
cium release (R
 
rel,i
 
(V
 
m
 
), where i is the peak or steady level) was
assessed by fitting the two state Boltzmann function:
 
(1)
 
where R
 
rel,i
 
[max] is the maximal release rate, V
 

 
 is the voltage at
half-maximal release rate, and k is the slope factor to the calcu-
lated data.
 
Intramembrane Charge Movement and Calcium Current
 
Intramembrane charge transfer and calcium current through
L-type calcium channels were calculated by measuring membrane
currents in response to depolarizing and hyperpolarizing pulses
as described in detail previously (Szentesi et al., 1997). Briefly,
the linear capacitive current was determined from hyperpolariz-
ing pulses of 
 

 
20 mV in amplitude. This was then scaled and sub-
tracted from the current measured during depolarizing steps.
The nonlinear capacitative current, representing intramem-
brane charge transfer, was integrated to give the amount of
charge moved during the pulse (Q). To assess the membrane po-
tential dependence of charge transfer (Q(V
 
m
 
)) the measured
charge was fitted with the Boltzmann function:
 
(2)
 
where Q
 
max
 
 is the maximal available charge, and V and k have
their usual meaning.
Calcium currents (ICa) were measured using 800-ms-long de-
polarizing pulses exploring the 50 to 60 mV voltage range. To
enable the subtraction of the linear capacitive component the
20-mV hyperpolarizing pulses were also extended to 800 ms in
duration. The external calcium concentration was elevated to 5
Rrel,i Vm( ) Rrel,i max[ ] 1 exp Vm V–( )– k⁄[ ]+{ }⁄ ,=
Q Vm( ) Qmax 1 exp Vm V–( )– k⁄[ ]+{ } ,⁄=
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mM as detailed above. The peak ICa versus voltage relationship
was fitted with:
(3)
where ECa is the calcium equilibrium potential, Gmax is the maxi-
mal conductance, and all other parameters have their usual
meaning. All currents, the amount of charge moved, and the
maximal conductance were normalized to fiber capacitance to
take the size of the individual fibers into account.
Calcium Efflux from HSR Vesicles
HSR vesicles were actively loaded with calcium, resulting in a
1.20  0.11 mol/mg protein average calcium content of the vesi-
cles. Calcium efflux was determined by measuring the extravesicu-
lar calcium concentration using a Fluoromax (SPEX Inc.) spec-
trofluorometer modified for absorption measurements by moni-
toring the transmittance at 710 and 790 nm, and calculating the
corrected absorbance change (A710  A790) as described earlier
(Sárközi et al., 1996). In brief, vesicles were suspended in the cu-
vette (final volume, 2 ml) in a medium containing the follow-
ing (in mM): 92.5 KCl, 1 MgCl2, 0.180 APIII, 0.054 CaCl2, 18.5
K-MOPS, and 1 ATP up to a final protein concentration of 260 g/
ml. Vesicles were actively loaded with calcium in the cuvette by the
addition of CaCl2. After completion of the ATP to ADP conversion,
ICa Vm ECa–( ) Gmax⋅ 1 exp Vm V–( )– k⁄[ ]+{ } ,⁄=
the release of calcium was initiated by the addition of 300 M thy-
mol. The samples were continuously stirred by special magnetic
stirrers having a mixing time of 0.2–0.5 s. Initial rate of release was
determined using the time segments of 10–50 s after the thymol
addition, since thymol exerted its full effect in a few seconds. The
effect of dantrolene was tested by the preincubation of the samples
with the appropriate concentration of dantrolene for 30 min be-
fore initiating the thymol-induced calcium release. The effect was
assessed as a decrease of the thymol-induced release.
Planar Lipid Bilayer Measurements
CHAPS solubilized RYR molecules were incorporated into planar
lipid bilayers (Tripathy and Meissner, 1996) formed across a 200-
m aperture of a nolrene cup using a lipid mixture composed of
phosphatidylethanolamine, phosphatidylserine and phosphati-
dylcholine in the weight ratio of 5:4:1. Lipids were dissolved in
n-decane up to a final concentration of 20 mg/ml, as described
in our previous reports (Szegedi et al., 1999). Reconstitution was
initiated in symmetric buffer solution (250 mM KCl, 100 M
EGTA, 150 M CaCl2, and 20 mM PIPES, pH 7.2), by adding a
small aliquot of the solubilized receptor to one side of the bilayer
chamber defined as the cytoplasmic (cis) side. K was used as a
charge carrier in the voltage-clamp measurements, and the cur-
rent signal was filtered at 1 kHz through an 8-pole lowpass Bessel
filter and digitized at 3 kHz using Axopatch 200 amplifier and
pClamp 6.03 software (Axon Instruments, Inc.). Channels with
Figure 1. Extracellular applica-
tion of dantrolene depresses cal-
cium transients in intact mouse skel-
etal muscle fibers. (A) Effect of dan-
trolene (25 M) on the indo-1
calcium transient elicited by a depo-
larization of 20 ms to 0 mV applied
every 30 s. (B) Time-dependent evo-
lution of the peak change in [Ca2]i
elicited by a 20-ms depolarization to
0 mV upon dantrolene application
and after washout. Data points cor-
respond to the mean value obtained
from four fibers. For each fiber, data
points were normalized to the peak
value measured in response to the
first depolarization. Here, and in
subsequent figures, open circles
(), closed circles (), and open
triangles () denote measurement
taken before, during, and after the
extracellular application of dantro-
lene, respectively.
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conductance 
400 pS were accepted as RYR. Open probability
values (Po) were calculated from 1-min segments of the current
traces. After each change of the measuring condition, at least 5
min was allowed to reach the new equilibrium, and then at least
5-min-long records were taken for each of the experimental con-
dition tested. In the case of dantrolene, 30-min incubation was
used before the current recordings. Measurements were per-
formed at 22–25C, dantrolene was applied in the cis chamber in
concentrations ranging from 1 nM to 50 M.
Chemicals
Fura-2 and indo-1 were purchased from Molecular Probes Inc.,
APIII was purchased from ICN Biomedicals. Protease inhibitors
were purchased from Boehringer, Merck, and from Sigma-
Aldrich. Lipids were obtained from Avanti Polar Lipids, [3H]rya-
nodine was purchased from DUPONT, and all other chemicals
were from Sigma-Aldrich.
For calcium efflux and bilayer experiments, a dantrolene stock
of 18 mM was prepared in DMSO, and the required aliquot was
added directly into the measuring chamber. This stock was diluted
in the external solution to determine the molar extinction coeffi-
cient of the drug (  14,700 cm1M1 at 390 nm). In Vaseline-
gap or silicone-clamp experiments, dantrolene was dissolved in the
applied aqueous solution to an attempted final concentration of
100 M. Unsolubilized particles were removed by filtering the so-
lution through 0.22-m filters (Millipore Corp.). Using the molar
extinction coefficient, this fully saturated solution was found to be
24.8 M and will be referred to as 25 M in results. Lower con-
centrations were obtained by diluting this fully saturated stock.
In statistical analyses, all values were expressed as mean 
SEM, statistical significance was calculated with the t test assum-
ing significance for P  0.05.
R E S U L T S
Dantrolene Suppresses Calcium Transients
Fig. 1 illustrates the effect of extracellular application of
25 M dantrolene on the calcium transients elicited by
short depolarizing pulses on intact mouse skeletal mus-
cle fibers using the silicone-clamp technique. Fig. 1 A
shows a series of indo-1 calcium transients elicited by 20-
Figure 2. Changes in (A) intracellular calcium concentration ([Ca2]i) and (B) the rates of calcium release from the SR (Rrel) at vari-
ous dantrolene concentration. Calcium transients were evoked with 100-ms-long depolarizations to 0 mV in fibers mounted into the Vase-
line gap. The first and second columns originated from the same fiber, whereas the traces in the third and fourth columns are from two
other fibers. In these fibers, the peaks of the calcium transients and those of Rrel in control were close (10%) to the values from the fiber
represented in the first column. Nevertheless, to ease the comparison between the different fibers, different scales were used for the last
two columns. With these, the control transients (not shown for 5 and 25 M dantrolene) would be equal in size in the figure to the traces
presented in the first column. Antipyrylazo concentrations ([APIII]) were 650, 613, and 823 M; Fura-2 concentrations ([Fura-2]) were
48, 35, and 111 M for the fibers with 1, 5, and 25 M dantrolene, respectively. The parameters for calculating Rrel were koff,M-P  9.4, 6.1,
and 3.5 s1; PVmax  1.32, 1.88, and 2.41 mMs1; kon,Ca-E  0.9, 1.5, and 1.7 M1s1; and koff,Ca-E  4.9, 2.2, and 4.4 s1, respectively. In this
and subsequent figures, where the Vaseline-gap technique was applied, Fura-2 was used to measure changes in [Ca2]i at, and close to, the
resting value, whereas APIII was used for large changes in [Ca2]i.
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ms-long depolarizing pulses to 0 mV applied every 30 s.
Application of dantrolene produced an 50% decrease
in the maximal amplitude of the calcium transient from
0.88  0.24 M (n  4), the effect being complete
within 2 min. Fig. 1 B shows the time-dependent
evolution of the mean maximum change in [Ca2]i
reached in response to a 20-ms duration depolarizing
pulse to 0 mV, in control conditions, and upon dan-
trolene application and washout. Data correspond to
the mean values obtained from four fibers. Values of
peak change in [Ca2]i from each fiber were normal-
ized to the peak value measured in response to the
first depolarization. In average, dantrolene produced a
58% suppression of the peak calcium transient, the ef-
fect being partly and slowly reversible upon dantrolene
washout. This effect of dantrolene was not associated
to any significant change in resting [Ca2]i, which,
within this series of measurements, exhibited a mean
value of 64  13 nM in control and 62  12 nM at the
time when dantrolene produced its full effect on the
peak [Ca2]i.
These measurements were repeated using the double
Vaseline-gap system to enable the calculation of SR cal-
cium release. Thus, Fig. 2 presents calcium transients
and the calculated rate of calcium release from the SR
(Rrel; see materials and methods) at different dan-
trolene concentrations. Measurements in dantrolene
were taken 5–10 min after the solution exchange. This
was, based on Fig. 1, believed to be long enough for the
drug to reach its binding site and exert its full effects.
As will be demonstrated in more detail later (see Figs.
4, 6, and Table I), we were unable to reach substantial
recoveries from the suppression caused by dantrolene
if the drug was present for several minutes in the bath-
ing solution. Therefore, Fig. 2 presents data from three
different fibers for the three different dantrolene con-
centrations (1, 5, and 25 M) tested. To ease the com-
parison among different fibers, traces are presented on
different scales that were selected to give equal maxima
for the transients in control.
Dantrolene caused a dose-dependent suppression of
[Ca2]i, reaching 65% at the highest concentration.
Figure 3. Calcium transients measured in the ab-
sence and in the presence of 5 M dantrolene. The
fiber was depolarized from the holding potential to
the voltages (Vm) indicated between the traces for
100 ms. Measurements were taken first in the con-
trol, and then starting 10 min after the exchange to
the dantrolene-containing solution. Note that the
drug decreased the amplitude of the calcium signals
at every potential tested, but it did not shift the
threshold for the appearance of detectable increase
in intracellular calcium concentration change.
[APIII]  605–643 M; [Fura-2]  28–35 M.
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The attenuation was present both in the rate of rise and
in the amplitude of the calcium signals. The transients
showed a continuous increase in control and after the
addition of 1 and 5 M dantrolene, whereas a definite
maximum, followed by a gradual decline was measured
if 25 M dantrolene was present in the external solu-
tion. All of these characteristic changes were reflected
in the calculated efflux rate of calcium from the SR. Al-
though 1 M dantrolene did not cause any measurable
alteration in Rrel, higher concentrations gradually sup-
pressed both the early peak and the quasi-steady com-
ponent of SR calcium release.
As demonstrated in Fig. 3 for 5 M dantrolene, the
above mentioned effects on [Ca2]i were present at ev-
ery membrane potential tested. Dantrolene attenuated
the calcium transients by suppressing the rate of in-
crease of both the early, fast elevation and the more
gradual increase observed after 30 ms into the depolar-
izing pulse. On average, the maximal increase in 5 M
dantrolene was found to be 0.9  0.2 M (n  7) for a
100-ms-long depolarization to 0 mV as compared with
1.8  0.3 M measured on the same fibers under con-
trol conditions. Although 1 M dantrolene did not at-
tenuate the maximal [Ca2]i significantly (from 1.5 
0.3 to 1.4  0.4 M, n  13), 25 M of the drug caused
a 53  8% suppression (from 1.6  0.3 to 0.7  0.1
M, n  9). These data were consistent with those ob-
tained on intact fibers (Fig. 1), confirming that fibers
retain their full dantrolene sensitivity after mounting
them into the double Vaseline-gap system.
Fig. 4 goes on to plot the maximal increase in [Ca2]i
in the whole voltage range examined to demonstrate
that dantrolene had similar effects at every membrane
potential. To ease the comparison between different fi-
bers and drug concentrations, all data from a given fi-
ber were normalized before averaging. For normaliza-
Figure 4. Voltage dependence of the peak of the cal-
cium transients at different dantrolene concentrations.
Measurements in each fiber and at each dantrolene con-
centration were taken as described in Fig. 3, first in con-
trol conditions (), and then in the presence of the
drug (). Additionally, dantrolene was removed from
the external solution before obtaining a final set of cal-
cium transients (washout, ). To ease the comparison
between different fibers and dantrolene concentrations,
the peak [Ca2]i for every transient in a given fiber was
normalized to the value measured under control condi-
tions at 0 mV in the given fiber. The average values for
the peak of [Ca2]i at 0 mV were 1.5  0.3 (n  13),
1.8  0.3 (n  7), and 1.6  0.3 M (n  9) for A–C, re-
spectively. Depolarizations to or below 70 mV did not
elicit any measurable increase in [Ca2]i and were not
included in the graph. Note that the scale in A is differ-
ent from that in B and C.
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tion, the maximum of the calcium transient measured
under control conditions with a depolarization to 0 mV
on the given fiber was used. Furthermore, Fig. 4 dis-
plays the results, again normalized, from measure-
ments where dantrolene was removed from the extra-
cellular medium as the last intervention during the ex-
periment. In these fibers, the full [Ca2]i versus voltage
excursion was completed three times, and, as is shown
in Fig. 4 A, the fibers remained fairly stable during such
interventions. This observation allowed us to conclude
that much of the suppression that remained after the
washout of dantrolene was due to the fact that the drug
was not completely removed from its binding site
within the period of 15–20 min necessary to complete
the measurements at all voltages. Fig. 4 A also demon-
strates that increasing the amplitude of the depolariz-
ing pulse beyond 100 mV, i.e., depolarizing the fibers
to 10 or 20 mV, did not significantly increase the
magnitude of the calcium transients in control. To re-
strict the number of depolarizing pulses to a minimum
necessary to assess the voltage dependence, pulses be-
yond 0 mV were not included into the experimental
protocol for the other two dantrolene concentrations.
Comparing the traces in Fig. 3 at 40 mV and the
data presented for control conditions and in the pres-
ence of dantrolene in Fig. 4 (B and C) reveals that the
drug did not, significantly, alter the membrane poten-
tial at which detectable increase in [Ca2]i was ob-
served (51.1  2.5 and 53.3  3.0 mV in control
and in the presence of 25 M dantrolene, respectively,
n  9). These data, taken together, confirm that dan-
trolene suppresses the depolarization-induced eleva-
tion of [Ca2]i in a generally voltage-independent man-
ner in mammalian skeletal muscle fibers.
SR Permeability Is Attenuated by Dantrolene
To describe the effects of dantrolene on the SR calcium
release process, the rate of calcium release was cor-
Figure 5. The effects of 5 M dantrolene on SR
calcium permeability. Traces were calculated from
the calcium transients presented in Fig. 3 as de-
tailed in materials and methods. Note that dan-
trolene suppressed both the early peak and the
maintained steady level at each and every mem-
brane potential (Vm) tested. The parameters of
the removal model were koff,M-P  8.2 s1, PVmax 
2.24 mMs1, kon,Ca-E  1.4 M1s1, and koff,Ca-E 
1.7 s1. The estimated SR content for this fiber
was 2.5 mM.
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rected for depletion of calcium in the SR and the ob-
tained transients were normalized to SR contents. This
content was found to be fairly stable over the fibers in-
cluded into the present study (1.8  0.1, 2.0  0.1, and
1.9  0.2 mM for the fibers subjected to 1, 5, and 25
M dantrolene; n  13, 7, and 9) and to be unaltered
by the treatment with dantrolene. Similarly, dantrolene
left the resting [Ca2]i ([Ca2]rest) as well as the param-
eters of the removal model unaltered. As an example,
the values of [Ca2]rest were found to be 109  17 nM
in control and 107  12 nM after the addition of 25
M dantrolene. The corresponding values of the pa-
rameters of the removal model, if fitted independently
in control and in the presence of the drug, were as fol-
lows: koff,M-P  8.5  2.1 and 5.2  1.6 s1, PVmax 
3.1  0.5 and 2.5  0.3 Ms1, koff,C-E  3.3  0.8 and
3.6  0.8 s1, and kon,C-E  2.1  0.4 and 2.0  0.4
Ms1. Therefore, in the calculations, we used the
same values for the removal parameters for control, in
the presence of the drug and after washout in most
fibers, unless they gave unrealistic Rrel records (e.g., large
negative phases after repolarization). In the latter case,
separate sets of parameters were used.
Fig. 5 presents SR calcium permeabilities calculated
from the calcium transients in Fig. 3. In this case, the
same set of removal parameters was used before and af-
ter the addition of the drug. Dantrolene caused a
marked suppression of both the early and the sustained
steady components of SR permeability at all membrane
potentials tested. This observation is presented in Fig. 6,
where pooled data of the two kinetic components of SR
permeability are shown as a function of membrane po-
tential in control in the presence of the drug and after
washout. The organization of Fig. 6 follows that of Fig.
4, individual data points were normalized before averag-
ing. To this end, Eq. 1 was fitted to the data (peak or
steady level versus voltage) in control for each and every
fiber and the obtained maximum (Eq. 1, Rrel,i[max])
was used for normalization. Fig. 6 reveals a dose-depen-
dent suppression of both the early peak and the steady
component of SR permeability reaching 
50% in case
of 25 M dantrolene. It also shows that, as expected
Figure 6. Voltage-dependent effects of dantrolene on the peak (left column) and on the steady level (right column) of SR calcium per-
meability. The steady level was measured as the average of the values during the last 20 ms of the test pulse. The voltage dependence of ei-
ther component was fitted with Eq. 1 in every fiber. The obtained maximum (Eq. 1, Rrel,i[max]) in control on the given fiber was used to
normalize the values before averaging and plotting them. The parameters obtained by fitting the voltage dependence with Eq. 1 and aver-
aged over the fibers are presented in Table I. The same fibers and symbols as in Fig. 4 are used.
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from the data on the calcium transients, no significant
recovery was achieved after the removal of the drug.
To quantify the suppression caused by the different
concentrations, Eq. 1 was fitted to the data (peak or
steady level versus voltage) in the presence and absence
of dantrolene and after washout in every fiber. The ob-
tained parameters, Pmax or SLmax (Eq. 1, Rrel,i[max] with
i  peak or steady level, respectively), the midpoint volt-
age, and the slope factor, are presented in Table I after
averaging. The data reveal that 1 M dantrolene did not
have any measurable effects on the depolarization-
induced increase in SR permeability. On the other hand,
5 and 25 M of the drug significantly (P  0.02) attenu-
ated both the early peak and the steady level. Although
the effect on the steady level was somewhat larger than
on the peak, 53  8 vs. 46  6% for 25 M, this differ-
ence did not prove to be statistically significant.
Comparing the voltage dependence of the differ-
ent components as well as the effect of dantrolene on
the voltage dependence did not reveal any systematic
difference or trend. The only statistically significant
change occurred at 25 M, where a shift toward more
positive membrane potentials was detected in the volt-
age dependence of the peak. The fact that dantrolene
had very little effects on the voltage dependence of
either component suggested a voltage-independent
block of SR permeability by the drug. This was con-
firmed by directly calculating the suppression in every
fiber in the 40 to 0 mV voltage range and averaging
these relative data. The largest and the smallest values
were, respectively, 0.63  0.14 (at 40 mV) and 0.45 
0.09 (at 30 mV) for the peak and 0.65  0.13 (at 0
mV) and 0.55  0.1 (at 30 mV) for the steady level
with 5 M dantrolene. Corresponding values in 25 M
were 0.59  0.06 (at 40 mV) and 0.43  0.08 (at 20
mV) for the peak and 0.51  0.02 (at 40 mV) and
0.39  0.05 (at 0 mV) for the steady level, none of
which was found to be significantly different. These
data establish that dantrolene attenuates SR permeabil-
ity in a voltage-independent manner. The extent of sup-
pression is equal for the two kinetic components, peak
and steady level, of SR permeability.
Intracellular Application Does Not Alter the Effective 
Concentration for Dantrolene
The following series of measurements were designed to
test whether or not extracellular application of dan-
trolene could somehow limit the access of the drug to its
putative intracellular binding site, since submicromolar
dissociation constants have been reported (150 nM;
Fruen et al., 1997) in vesicles. To this end calcium tran-
sients were measured in fibers that had been pressure-
injected with an “internal-like” solution containing 25
M dantrolene. Due to the low solubility of the drug in
water, this involved the injection of a large volume rela-
tive to that of the cell. To ensure that the injection had
minimal effects on fiber conditions, the silicone-clamp
technique was used, where injections of large volumes
are known to cause little, if any, damage.
Under our standard conditions of microinjection,
the concentration of the fluorescent dye present in the
injected solution is estimated to be diluted by a factor
of 5–10, once fully equilibrated within the entire vol-
ume of the cell (Csernoch et al., 1998). In these experi-
ments, as dantrolene was present at 25 M in the in-
jected solution, its final concentration within the fibers
was believed to reach 2.5–5 M. This, of course, is a
rough estimation. It assumes that dantrolene was diffus-
ing freely within the fibers, and, furthermore, that in-
tracellular binding (within the insulated part) did not
alter its final concentration in the silicone-free portion
of the fibers.
T A B L E  I
Voltage Dependence of SR Calcium Permeability
Peak Steady level
Maxb V k Maxb V k
ms1 mV mV ms1 mV mV
Control (n  13) 1.16  0.27 23.4  2.0 8.2  0.5 0.39  0.11 23.1  2.1 8.1  0.6
1 M dantrolene 1.09  0.31 20.1  2.0 9.3  0.4 0.37  0.11 18.1  2.7 9.1  0.7
Washout 0.91  0.33 15.0  5.9 10.9  1.5a 0.30  0.13 19.5  4.4 8.3  1.1
Control (n  7) 1.18  0.05 22.4  1.3 7.5  0.3 0.49  0.04 16.6  1.9 8.8  0.4
5 M dantrolene 0.75  0.13a 17.9  2.6 7.7  0.6 0.29  0.05a 16.1  2.2 7.6  0.4a
Washout 1.04  0.14 15.6  2.5a 9.3  1.0a 0.33  0.05a 20.3  0.6 6.9  0.7a
Control (n  9) 1.53  0.14 21.8  1.4 7.7  0.4 0.57  0.07 22.5  2.8 6.7  0.5
25 M dantrolene 0.94  0.20a 16.4  1.8a 8.4  0.4 0.25  0.04a 22.0  2.6 5.7  0.8
Washout 0.81  0.23a 16.8  2.9 7.8  0.1 0.21  0.08a 23.2  4.1 4.5  0.1
Parameter values obtained by fitting Eq. 1 to the voltage dependence of SR permeability. Values represent mean  SEM.
aSignificant difference from the control.
bDenoted as Rrel,i[max] with i  peak or steady level in Eq. 1.
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Fig. 7 shows the results from a fiber where dantrolene
was injected a few minutes before voltage clamping and
giving depolarizing pulses. In this fiber, a 20-ms-long
pulse to 0 mV was applied every minute. Fig. 7 A shows
calcium transients measured 13 (trace a), 53 (trace
b) and 103 min (trace c) after dantrolene had been in-
jected into the fiber. Each trace is the average of five
consecutive calcium transients. Fig. 7 B follows the evo-
lution of the change in the peak of [Ca2]i over the
course of the experiment. No significant suppression of
the peak [Ca2]i occurred under these conditions, only
toward the end of the experiment. However, note that
the mean value for the maximum of the first calcium
transients obtained in these injected fibers was 0.76 
0.1 M (n  8) as compared with 0.88  0.24 M in
control cells (Fig. 1).
To test the possibility that the relatively little, if any,
effect of injected dantrolene was due to its fast diffu-
sion, the above experiments were repeated on fibers
isolated from rats. In these fibers, the length of diffu-
sion was, on average, twice that in mouse fibers. The in-
set in Fig. 7 displays the evolution of the relative ampli-
tude of the calcium transients from these experiments.
As in Fig. 1 B, the first calcium transient was used for
normalization and the normalized values were aver-
aged over the fibers. The injection of dantrolene
caused an 20% decrease in the amplitude of the cal-
cium transients that was complete within 15 min.
Assuming that the first calcium transient (taken 5
min after injection) represents the control situation,
these data suggest that intracellularly applied dantro-
lene has relatively little effect on the micromolar con-
centration. The magnitude of this effect is comparable
to that seen with extracellular application. If, on the
other hand, the injected dantrolene exerted the major-
ity of its effects before the first calcium transient was
Figure 7. Effect of intracellularly applied dan-
trolene on calcium transients measured in intact
mouse and rat fibers. (A) Indo-1 calcium tran-
sients measured in response to a 20-ms-long depo-
larization to 0 mV at various times after a microin-
jection of dantrolene into a mouse fiber. Each
trace corresponds to the average of five successive
transients. (B) Time-dependent evolution of the
depolarization-induced peak change in [Ca2]i af-
ter the microinjection of dantrolene into the same
fiber. Horizontal bars (labeled a–c) indicate the
period used to calculate the transients presented
in A. The inset shows pooled data (n  3) from ex-
periments repeated on fibers isolated from rats to
increase the diffusion length. The evolution of the
amplitude of the calcium transients is displayed af-
ter normalizing to the first calcium transient mea-
sured on the corresponding fiber.
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taken, then additional application of external dantro-
lene should have little, or no, further effect.
Fig. 8 tests this hypothesis by showing results from
two other fibers that were injected with dantrolene. In
Fig. 8 (A and B), measurements were taken 30 min af-
ter dantrolene had been injected. The fiber was repeat-
edly depolarized using 20-ms-long pulses to 0 mV, and
the effect of a brief, transient extracellular application
of 25 M dantrolene was tested. Results show that,
under these conditions, extracellular dantrolene still
maintained its potency to partially depress the depolar-
ization-induced increase in [Ca2]i. This conclusion is
further strengthened by the results shown in Fig. 8 (C
and D), which were obtained from another fiber 1 h
after dantrolene had been injected. A 30-ms-long pulse
to 0 mV was applied every minute. Traces shown in Fig.
8 C correspond to the average of three successive cal-
cium transients measured in control (a), and in the
presence of 0.5 (b), 12.5 (c), and 25 M (d) extracellu-
lar dantrolene. In this experiment, the presence of
each dantrolene concentration was maintained for 5
min and followed by a 5-min washout period. Under
these conditions, dantrolene at 12.5 and 25 M had an
effective, dose-dependent depressing effect on the
peak calcium transients. Similar results were obtained
on four other fibers with 40  2% and 67  11% sup-
pression at 12.5 and 25 M dantrolene, respectively.
Overall, these results strongly argue against the possi-
bility that dantrolene, when applied intracellularly
would suppress calcium transients at a much lower
concentration than when applied in the extracellular
medium. This implies that the surface membrane does
Figure 8. Dantrolene-injected fibers are still sus-
ceptible to extracellular dantrolene application.
Results shown in A–D were obtained from two dis-
tinct fibers that had been injected with dantrolene.
(A) Indo-1 calcium transients were elicited by 20-
ms-long depolarizations to 0 mV in control (a),
and 2 min (b) and 6 min (c) after a brief extracel-
lular application of 25 M dantrolene. (B) Time-
dependent evolution of the peak change in [Ca2]i
before and after the application of dantrolene. (C)
Indo-1 calcium transients elicited by a 30-ms dura-
tion pulse to 0 mV in control (a), and upon extra-
cellular application of 0.5 (b), 12 (c), and 25 M
(d) dantrolene. (D) Corresponding time-depen-
dent evolution of the peak change in [Ca2]i dur-
ing the course of the experiment.
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not limit the ability of dantrolene to access its binding
site.
Effects of Dantrolene on the Dihydropyridine Receptor
Results so far suggest an interaction of the drug with a
step of excitation-contraction coupling subsequent to
the voltage-sensing event. To directly exclude the in-
volvement of the voltage sensor as the putative dan-
trolene-binding site, its two functional manifestations,
intramembrane charge movements and L-type calcium
currents, were measured in separate sets of experi-
ments. These experiments also tested the possibility of
any “backward” flow of information in the coupling
process, i.e., did the suppression of SR calcium release
affect the functioning of the DHPRs.
Fig. 9 A presents nonlinear capacitive currents repre-
senting intramembrane charge movement in the ab-
sence and presence of 25 M dantrolene. The tran-
sients were recorded in response to 100-ms-long depo-
larizing pulses exploring the 80 to 0–mV voltage
range. The actual currents were normalized to linear
capacitance to take into account the differences in fi-
ber size, when comparing different fibers, or any possi-
ble change in passive electric properties during the ex-
periments. However, the linear capacitance, on aver-
age, did not change significantly during the course of
these experiments since it was found to be 13.7  0.7
nF (n  12) under control conditions and 13.7  0.9
nF on the same cells after the addition of dantrolene.
Thus, the fibers were stable not only from the aspect of
calcium release, but also electrically.
To assess the voltage dependence of charge transfer
the currents were integrated and Eq. 2 was fitted to the
charge versus voltage data both before and after the ad-
dition of dantrolene. Average values of the parameters
from these fits are presented in Table II. To visualize
Figure 9. Intramembrane charge move-
ment in the absence and presence of 25 M
dantrolene. (A) Nonlinear capacitive currents
representing the movement of intramem-
brane charge. The currents were obtained in
response to 100-ms-long depolarizations to
various membrane potentials (Vm). Currents
are presented after normalization to fiber ca-
pacitance (14.4 and 16.0 nF, control and dan-
trolene). (B) Voltage dependence of charge
transfer. The amount of charge moved was fit-
ted with Eq. 2, and the data are presented as
normalized to the fitted maximum and aver-
aged over the fibers (n  9). Superimposed
are the theoretical two-state Boltzmann func-
tions fitted to the averaged data. The parame-
ters of the curves are as follows: V  40.8
and 36.4 mV; and k  15.3 and 18.9 mV for
control and dantrolene, respectively.
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the effects of dantrolene on the voltage dependence of
charge transfer, Fig. 9 B plots the normalized charge,
amount of charge at a given voltage divided by Qmax de-
termined under the given condition in that fiber, as a
function of membrane potential during the test pulse.
Although there seemed to be a slight shift of the volt-
age dependence to the right along the voltage axis, by 5
mV, together with a slight decrease in steepness (an in-
T A B L E  I I
Effect of 25 M Dantrolene on Intramembrane Charge Movement and on the L-Type Calcium Current
Charge movement ICa
Qmax V k Gmax V k ECa
nCF1 mV mV SF1 mV mV mV
Control 23.8  2.4 38.9  2.3 13.1  1.1 200  16 10.8  1.5 7.1  0.5 73.2  2.6
Dantrolene 27.6  3.9 33.5  3.3 15.8  1.0 143  8a 8.2  1.5 6.5  0.7 80.1  4.3
Parameter values obtained by fitting Eq. 2 or 3 to the voltage dependence of intramembrane charge movement or L-type calcium current, respectively. 
aSignificant difference from the control.
Figure 10. L-type calcium cur-
rents in the absence and presence of
25 M dantrolene. (A) Calcium cur-
rents were elicited by 800-ms-long
depolarizations exploring the 40
to 60 mV voltage range in 10-mV
increments in control (Aa) and after
the addition of the drug (Ab). (B)
Calcium currents from a fiber where
dantrolene was already present in
the external solution when the ex-
periment started. All current traces
were normalized to the linear capac-
itance of the given fiber (7.3, 6.2,
and 17.6 nF for Aa, Ab, and B, re-
spectively). (C) Current-voltage rela-
tionship for the calcium current
measured in control and, on the
same fibers, after the addition of the
drug (n  8). Superimposed are
the theoretical voltage dependencies
obtained by fitting Eq. 3 to the aver-
aged data points with Gmax  184
and 111 SF1; V  8.3 and 14.6
mV; k  7.7 and 5.5 mV; and ECa 
73.4 and 71.2 mV in control and in
the presence of dantrolene. (D)
Current-voltage relationship in con-
trol conditions and in the presence
of dantrolene. In this case, all of
those fibers (n  10) were included
with the control where the experi-
ment started with normal external
solution, whether or not dantrolene
was afterwards applied. Further-
more, only those fibers were aver-
aged under dantrolene (n  10)
where the drug was present from the
beginning of the experiment, i.e.,
no control series were measured be-
forehand (as in B). Superimposed
curves represent the least squares fit
of Eq. 3 with Gmax  196 and 138
SF1; V  8.3 and 8.7 mV; k 
7.7 and 6.9 mV; and ECa  72.4 and 79.6 mV in control and in the presence of dantrolene. (E) Time constant of current inactivation as a
function of membrane voltage. Same fibers as in D are used.
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crease in parameter k) these changes did not prove to
be statistically significant. Similarly, the elevation of the
total amount of available charge, from 23.8  2.4 to
27.6  3.9 nCF1 on average (n  10), remained
within the limits of statistical variation.
Another manifestation of DHPR function, the L-type
calcium current was measured in a separate set of ex-
periments using 800-ms-long depolarizing pulses and el-
evated calcium concentration in the external solution
while exploring a wider, from 50 to 60 mV, voltage
range. Calcium currents were readily observed under
these conditions, and they displayed all the usual char-
acteristics in control (Fig. 10 Aa) as described earlier
(McDonald et al., 1994). Currents showed a relatively
slow activation at negative membrane potentials that be-
came faster with increasing depolarization. After reach-
ing a peak, 160 ms into the pulse, currents slowly inac-
tivated with a time constant on the order of 0.2–0.5 s
(0.26  0.02 s at 0 mV; Fig. 10 E). After the addition of
25 M dantrolene, currents became smaller and their
inactivation was drastically slowed down (Fig. 10 Ab). To
describe the voltage dependence of current activation,
the maximal current, averaged over the fibers, was plot-
ted as a function of membrane potential in Fig. 10 C
and fitted with Eq. 3. Although the fit revealed a sub-
stantial decrease in maximal conductance, from 184 to
111 SF1, the other parameters describing the voltage
dependence remained, essentially, unaltered.
Since the alteration in calcium current seen in the
presence of dantrolene resembled that of current run-
down (Markwardt and Nilius, 1990), in another set of
experiments calcium currents were measured on fibers
where dantrolene was present from the beginning of
the experiment. Fig. 10 B displays such currents, con-
firming that much of the alteration seen going from
Fig. 10 Aa to 10 Ab was due to rundown rather than to
the presence of dantrolene itself. Fig. 10 D goes on to
plot the current voltage relationship for all fibers, pro-
vided that the measurements in the given condition
were the first series of depolarizations. Fitting Eq. 3 to
the data points revealed a slight suppression of maxi-
mal conductance and no significant change in any
other parameter. This observation was confirmed by fit-
ting the voltage dependence in each fiber and then av-
eraging the obtained parameters (Table II). Although
the maximal conductance was reduced from 200  16
to 143  8 SF1, the change in the other parameters, a
slight shift to more positive voltages in V and in the
equilibrium potential with a small increase in steep-
ness, was found not to be significant.
Since the maximal conductance was indeed sup-
pressed by dantrolene, it was of interest to see whether
some of the alteration in inactivation was also due to
the presence of the drug. Thus, Fig. 10 E plots the time
constants of inactivation, obtained by fitting a single ex-
ponential function to the decaying part of the current
traces, as a function of the membrane potential. As for
Fig. 10 D, only those data were included in the figure
where the measurements in the given condition, con-
trol or dantrolene, comprised the first series of records.
As demonstrated in Fig. 10 E, dantrolene caused a
three- to fourfold increase (from 0.26  0.02 to 0.80 
0.18 s at 0 mV) in the time constant of inactivation at
every membrane potential tested. It is not clear at
present, whether the decrease in the conductance
L-type calcium channels and in the rate of inactivation
is a direct or an indirect effect of dantrolene on the
DHPRs. Nevertheless, the data establish that the drug
does not affect the voltage sensor of EC coupling in a
way that could explain its effects on SR permeability.
Therefore, the putative binding site must lay further
downstream in the steps of events leading to the open-
ing SR calcium channels.
Dantrolene Inhibits Calcium Efflux from HSR Vesicles
Previous sections have established that 25 M dantro-
lene suppresses SR permeability by 50% without al-
tering the voltage sensor function of the DHPRs. How-
ever, they do not exclude a putative binding site to be
located in the surface membrane that might influence
the interaction of DHPRs and the RYRs. To exclude
this possibility, HSR vesicles were prepared, and the ef-
fect of dantrolene was tested on the efflux of calcium.
HSR vesicles were actively loaded with calcium in the
presence of ATP and, after the ATP was essentially used
up, to prevent reuptake during release, calcium efflux
was initiated by the addition of 300 M thymol, a po-
tent activator of RYRs (Palade, 1987). As demonstrated
in the inset (marked HSR) in Fig. 11, the addition of
thymol caused a massive release of calcium, which
eventually led to the complete emptying of the vesicles.
This effect of thymol was specific to RYR, since the ad-
dition of the drug to LSR vesicles did not initiate any
calcium release (Fig. 11, inset marked LSR).
Since thymol could not be removed from the solu-
tion during the course of an experiment, Fig. 11 com-
pares different experiments for the different dan-
trolene concentrations. However, it should be noted
that the amount of protein and the amount of calcium
loaded into the HSR vesicles were identical for the dif-
ferent experimental conditions. The latter was ensured
by the addition of known and set amounts of calcium
into the extravesicular space, and by continuously mon-
itoring its uptake into the vesicles. The amounts of cal-
cium released, therefore, can be compared directly.
The presence of dantrolene in the extravesicular me-
dium substantially reduced the rate of calcium efflux
from HSR vesicles. The attenuation of the maximal re-
lease rate reached 44  11% at 12 M, a value that is
comparable with that obtained from intact fibers for
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the suppression of SR permeability (Table I), suggest-
ing that the putative dantrolene-binding site was fully
preserved during the isolation of the HSR vesicles.
These data clearly place the putative binding site to be
on a SR-associated molecule.
Dantrolene Does Not Influence the Isolated RYR
Previous experiments (Suarez-Isla et al., 1986; Nelson
et al., 1996) used SR vesicles incorporated into planar
lipid bilayers to explore the effects of dantrolene on
RYR function. However, those measurements do not di-
rectly confirm whether the binding site for dantrolene
is on the RYR itself, or it is on a closely associated pro-
tein. Therefore, we purified the calcium release chan-
nel and used the purified protein for bilayer studies.
Fig. 12 demonstrates the effects of high (50 M) dan-
trolene concentration on the gating of the RYR. The
traces are representative (2.2-s long) segments of cur-
rent records from an experiment that lasted for more
than an hour. The incorporation was initiated under
control conditions with 50 M [Ca2] on either side of
the bilayer. Under these conditions (Fig. 12 A), the
channel displayed an open probability (Po) of 0.175
and a conductance of 555 pS, as expected from earlier
studies. However, in contrast to previous results using
SR vesicles, the addition of 50 M dantrolene into the
cis chamber influenced neither the open probability
nor the conductance of the purified channel. This is
shown in Fig. 12, B and C, at 5 and 30 min after the ad-
dition of the drug, respectively. The inset of Fig. 12 fol-
lows the evolution of the open probability of the chan-
nel during the 30-min after the addition of the drug,
demonstrating that dantrolene did not have any tran-
sient or long-term effects on channel gating.
Fig. 12 goes on to demonstrate that the drug did not in-
terfere with the ability of well-known regulators to modu-
Figure 11. Concentration-dependent effects of dantrolene on thymol-induced calcium release from heavy SR vesicles. Vesicles were ac-
tively loaded with calcium and preincubated with dantrolene for 30 min. Calcium release was initiated by the addition of 300 M thymol.
Calcium release was calculated as the maximal rate of rise after the addition of thymol. Data present averages from individual experiments
(number of experiments given in parentheses) where the protein content and the amount of calcium loaded into the vesicles were the
same. Insets show actual records of calcium release from HSR (bottom) and LSR vesicles (top), monitored as the amount of extravesicular
calcium with APIII, from representative experiments at each concentration tested. Transient upward deflections mark the addition of thy-
mol (Thymol). Note that neither thymol nor dantrolene had any effect on LSR vesicles, whereas dantrolene inhibited the thymol-induced
calcium release in HSR vesicles.
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late channel function. First, the concentration of calcium
was reduced in the cis chamber (Fig. 12 D), which re-
sulted in a drastic reduction in Po (to 0.001). This was fol-
lowed by the readministration of calcium (Fig. 12 E), and
then the addition of 3 mM ATP (Fig. 12 F) into the cis
chamber. This first restored the Po to its starting value and
then resulted, as expected, in an activation of the channel
(Po  0.874). Finally, the addition of ryanodine caused
the characteristic transition to a half-conducting state.
Since previous experiments suggested a high affinity,
activatory binding site for dantrolene (Nelson et al.,
1996), again using SR vesicles for incorporation, an-
other set of experiments were used to test if the puri-
fied RYR would be influenced by 1 nM dantrolene. The
drug in this low concentration neither altered the gat-
ing nor the pharmacology (activation by calcium, ATP,
and caffeine, and inhibition by ruthenium red) of the
purified channel (unpublished data).
These data establish that dantrolene has no effect, ei-
ther transiently or permanently, on the gating behavior
of the purified calcium release channel incorporated
into planar lipid bilayers. The fact that the pharmacol-
ogy of the channel is retained renders the possibility of
major modification during the purification, unlikely.
Taken together, these data strongly argue against the
possibility of the binding site for dantrolene being on
the purified ryanodine receptor itself.
D I S C U S S I O N
For the first time, these experiments give a complete
account of the effects of dantrolene on steps of excita-
tion-contraction coupling in mammalian skeletal mus-
cle fibers. They explored the voltage sensing function
of the DHPRs by measuring both intramembrane
charge movements and L-type calcium currents. They
Figure 12. The effect of 50 M dantrolene on the gating properties and pharmacology of the purified RYR. Incorporation was initiated
in symmetric 250 mM KCl with 50 M calcium concentration in the cis chamber. Holding potential was 40.3 mV, channel openings are
downward deflections. Horizontal lines before each current record mark the closed state. (A) Single-channel recording in control condi-
tions. (B and C) Representative segments of single-channel behavior taken 5 and 30 min after the additions of dantrolene. (D–G) Single-
channel currents measured after the successive additions of EGTA (D), calcium (E), 3 mM ATP (F) and, finally, RYR (G) into the cis cham-
ber. Inset shows the evolution of the Po starting 2 min before the addition of dantrolene (open symbols) ending with the record shown in
C. All recordings are from a single experiment.
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also assessed the functioning of the RYRs by comparing
calcium release flux from the SR in intact fibers to cal-
cium efflux from HSR vesicles and to alterations in sin-
gle-channel properties of the calcium release channel.
Dantrolene was found not to interfere with the voltage-
sensing event, but was found to suppress SR calcium
permeability and calcium efflux to a similar extent. On
the other hand, the drug failed to alter the single-chan-
nel properties and the basic pharmacology of the iso-
lated RYR. These data place the putative binding site to
be on a molecule associated with the SR membrane,
but exclude the purified calcium release channel itself.
Calcium Release from the SR
Dantrolene has been in use for treating MH for more
than three decades (Hainaut and Desmedt, 1974). Very
early it has been described that the drug suppresses
twitch force (Flewellen et al., 1983) without affecting
the contractile proteins or the SR calcium pump
(Brocklehurst, 1975). The latter were also confirmed in
these experiments since the drug did not influence the
uptake of the SR vesicles (unpublished data) and it did
not have any nonspecific membrane effects (Fig. 11).
In the late 70s and early 80s, several groups (Desmedt
and Hainaut, 1977; Kovács et al., 1983) demonstrated
the suppression of calcium signals by dantrolene.
These measurements used invertebrate striated muscle
fibers (barnacle and frog, respectively) and the obser-
vation, although hypothesized, has not been confirmed
on mammalian preparations. Due to the limitations of
techniques present at that time, a quantitative analysis
of the suppression of the depolarization-induced in-
crease in [Ca2]i as a function of drug concentration
could not be performed. Here, we demonstrate that
the calcium transients are attenuated by 53  8% in
the presence of 25 M dantrolene, whereas 1 M is
without any effect. However, it should be stressed that
the suppression at 25 M was most likely far below the
possible saturation of the effect of the drug, but its in-
solubility in the aqueous environment prevented the
application of higher concentrations. Nevertheless, the
attenuation presented in these experiments should
provide a useful reference to the actual effect seen with
in vivo applications.
Due to the lack of data on calcium transients from
mammalian skeletal muscle fibers in the presence of
dantrolene, no account on the effects of the drug on
SR calcium release has been published so far. Not only
is this true for mammalian skeletal muscle but, to our
knowledge, also for striated muscle cells from other
classes of vertebrates or invertebrates. These experi-
ments would be of special interest since lower verte-
brates have been shown to express two isoforms of RYR
in their skeletal muscle (Olivares et al., 1991), and dan-
trolene has been reported to affect cardiac cells less
than striated muscle fibers (Van Winkle, 1976; Cham-
berlain et al., 1984; Fruen et al., 1997). Furthermore,
cardiac glycosides, specific for cardiac over the skeletal
isoform of RYR, have been reported to influence the
two kinetic components of SR calcium release differ-
ently in frog skeletal muscle (Sárközi et al., 1996).
In mammalian fibers predominantly expressing the
skeletal isoform of RYR, we haven’t found any significant
difference between the effects on the two kinetic compo-
nents, peak and steady level, of SR permeability (Table
I). This observation is similar to that reported for low
(10 M) concentrations of tetracaine on the same prep-
aration (Csernoch et al., 1999b). These findings suggest
a close and tight coupling between these two compo-
nents, and favor the hypothesis that they both originate
from the skeletal isoform of RYR. Considering that caf-
feine antagonizes the effects of dantrolene (Ohta et al.,
1990), the augmentation of both the peak and the
steady level of SR permeability by caffeine (Csernoch et
al., 1999a) also strengthens the conclusion above.
Location of the Putative Dantrolene-binding Site
There is a detailed description in the literature of re-
duced [3H]ryanodine binding to and reduced calcium
efflux from SR vesicles in the presence of dantrolene or
its water-soluble analogue azumolene (Francis, 1978;
Tian et al., 1991; Fruen et al., 1997). On the other
hand, some reports failed to demonstrate any modifica-
tion in [3H]ryanodine binding to HSR vesicles by dan-
trolene or azumolene (Palnitkar et al., 1997). The ex-
tent of the suppression of calcium efflux reported here,
44% for 12 M dantrolene at room temperature (Fig.
11), is consistent with, or slightly smaller than, earlier
data that showed a 70% reduction of [3H]ryanodine
binding at 36C (Fruen et al., 1997). The fact that it is
similar to the value reported for the suppression of SR
permeability (40–50%, Table I), is of greater impor-
tance. This clearly suggests that all of the suppression
seen on intact cells—under the conditions and the mi-
croscopic arrangement of EC-coupling proteins close
to, or most likely identical with, that in vivo—was due to
an effect mediated through an SR-bound protein. This
is substantiated by the finding that dantrolene, if ap-
plied intracellularly, did not have significantly higher
affinity for its putative binding site.
Whether the putative dantrolene-binding site could
be equated with the RYR itself, or not, has been a long
controversy in the literature. Recent biochemical data
link the binding site of [3H]azidodantrolene to a 160-
or a 172-kD protein (Palnitkar et al., 1999) that is likely
to be the NH2-terminal portion of the skeletal type RYR
isoform (Paul-Pletzer et al., 2001). Single-channel data
from purified calcium release channels that could re-
solve the controversy, were not available, to our knowl-
edge, in the literature. Previous studies used either SR
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membrane suspensions (Suarez-Isla et al., 1986) or
HSR vesicles incorporated into lipid bilayers (Nelson et
al., 1996) for studying the effect of dantrolene. In ei-
ther case, associated SR membrane proteins were
present in the preparation, and both groups described
a suppression of channel activity in the presence of mi-
cromolar dantrolene. Here, we incorporated the puri-
fied receptor into planar lipid bilayers and were unable
to detect any change in channel activity or pharmacol-
ogy in the presence of 50 M dantrolene (Fig. 12). In
contrast to the measurement of Nelson and co-workers
(Nelson et al., 1996), 1 nM dantrolene failed to en-
hance the activity or pharmacology of the purified RYR
(unpublished data). These observations either exclude
the possibility of the RYR itself being the molecular tar-
get for dantrolene or establish that, although the chan-
nel retains other regulatory sites during isolation, it
loses the binding site for dantrolene.
Effects of Dantrolene of DHPR Function
Previous studies on the effect of dantrolene on in-
tramembrane charge movements in frog skeletal mus-
cle have revealed a slight reduction in total charge
(Hui, 1983) together with a shift of the voltage de-
pendence toward more positive membrane potentials
(Hui, 1983; Jong et al., 1997). The reduction in Qmax
(20%) was attributed to the loss of Q, the delayed
component of intramembrane charge (Hui, 1983; Jong
et al., 1997). Under our experimental conditions, the
total amount of charge was not altered significantly,
similarly to other estimations on frogs (Morgan and
Bryant, 1977). On the other hand, since delayed com-
ponents are not pronounced on the nonlinear capaci-
tive currents recorded from mammalian skeletal mus-
cle fibers, the lack of any reduction in Qmax might sim-
ply reflect the difference in species. The changes
introduced by dantrolene in the voltage dependence in
frog muscle fibers, as a trend, were observed in these
experiments too (Table II). Although the changes did
not prove to be significant, the voltage dependence was
slightly shifted to the right along the voltage axis while
its steepness was reduced. Since the suppression of cal-
cium release influences intramembrane charge move-
ment (Pizarro et al., 1991; Jong et al., 1995), the data
presented here are consistent with a model where the
action of dantrolene on intramembrane charge was the
consequence of its effect on SR calcium release.
It has been reported that dantrolene does not influ-
ence L-type calcium currents in frog twitch muscle fibers
(Cota and Stefani, 1984). Similar studies, to our knowl-
edge, are not available for mammalian fibers. Here, we
found no alteration in the voltage dependence of cur-
rent activation, which is in line with the data of Cota and
Stefani (1984). However, both the maximal conductance
and the rate of inactivation were reduced. In addition,
the time constant for inactivation followed a “U-shaped”
voltage dependence, both in control and after the addi-
tion of the drug. There is no clear explanation, at
present, for these discrepancies, although species differ-
ences could underlie the different results.
To explain the observed voltage dependence and
dantrolene action on current inactivation three possi-
bilities should be considered: (1) the effect of reduced
calcium current or SR calcium release; (2) direct action
of the drug on the DHPR; and (3) retrograde effect
from the putative intracellular dantrolene-binding site.
The “U-shaped” voltage dependence of the time con-
stant strongly argues in favor of a current and/or cal-
cium-dependent inactivation, which could be due to ei-
ther of the following: (1) the depletion of calcium in
the restricted space of the t-tubular system; (2) a direct
effect of the calcium ions passing through the L-type
calcium channel itself; or (3) calcium ions released
from the SR. Plotting the time constant as a function of
the peak current in the control (unpublished data)
gave a linear function, further strengthening the above
idea. However, a similar plot in the presence of dan-
trolene gave a straight line with a different slope, indi-
cating that the shift seen in the presence of the drug
could not be due, simply, to a reduction in current.
SR calcium release, known to be important in the
heart, seems unlikely to be the cause of current inacti-
vation under our experimental conditions. The pres-
ence of 20 mM EGTA in the internal solution should
have reduced the change in [Ca2]i even in the rela-
tively restricted compartment of the triadic space (see
calculations in Pape et al., 1998). Furthermore, to test
for SR calcium release as a major contributor to inacti-
vation under these experimental conditions, we mea-
sured calcium currents in the presence of thymol and
found no significant decrease in the time constant in
spite of the increased release (unpublished data). Simi-
larly, the slight, although significant, decrease in cal-
cium permeability (Table II) can hardly underlie such
dramatic change in t-tubular calcium concentration
that could explain the action of dantrolene.
It should be stressed that the properties mentioned
above do not, inevitably, rule out the current and/or cal-
cium dependence of inactivation. Nevertheless, they sug-
gest that other possibilities, such as voltage dependence
or an interaction between dantrolene or its binding site
with the DHPR, should be considered. In this frame-
work, the drug does not influence the normal voltage
sensing machinery for activation (compare intramem-
brane charge movements in the absence and presence
of the drug in Fig. 9), but interferes with (slows the tran-
sition of) those responsible for inactivation.
This brings up the possibility that a retrograde effect
from the putative intracellular dantrolene-binding site
or from the altered gating of RYR would be responsible
374 Dantrolene and EC Coupling in Mammalian Skeletal Muscle
for the observed effects. The latter is supported by data
obtained on dyspedic myotubes from mice, where
L-type calcium currents were reduced and the gating
kinetics of the calcium channels was altered (Avila and
Dirksen, 2000). Thus, dantrolene could, through af-
fecting the RYRs, alter the properties of L-type calcium
currents in mammalian skeletal muscle. Taken to-
gether, although the data in control would suggest a
strong current and/or calcium dependence of inactiva-
tion, the measurements in the presence of dantrolene
argue in favor of a retrograde effect from the SR.
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